CIK 0000872589
- Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- Operating
- EIN
- 133444607
- Phone
- +1 914-847-7000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $59,162,329
- in 14 filings, $13.9M under 10b5-1 plans
Net −$59,162,329. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-17 | MURPHY ANDREW J Co-Chief Scientific Officer | Sale 10b5-1 | −93 | $949.69 | $88K | 51,697 |
| 2026-11-17 | MURPHY ANDREW J Co-Chief Scientific Officer | Sale 10b5-1 | −74 | $950.61 | $70K | 51,623 |
| 2026-11-17 | MURPHY ANDREW J Co-Chief Scientific Officer | Sale 10b5-1 | −298 | $951.75 | $284K | 51,325 |
| 2026-11-17 | MURPHY ANDREW J Co-Chief Scientific Officer | Sale 10b5-1 | −220 | $952.75 | $210K | 51,105 |
| 2026-11-17 | MURPHY ANDREW J Co-Chief Scientific Officer | Sale 10b5-1 | −671 | $953.69 | $640K | 50,434 |
| 2026-11-17 | MURPHY ANDREW J Co-Chief Scientific Officer | Sale 10b5-1 | −313 | $954.45 | $299K | 50,121 |
| 2026-11-17 | MURPHY ANDREW J Co-Chief Scientific Officer | Sale 10b5-1 | −313 | $955.48 | $299K | 49,808 |
| 2026-11-17 | MURPHY ANDREW J Co-Chief Scientific Officer | Sale 10b5-1 | −346 | $956.70 | $331K | 49,462 |
| 2026-11-17 | MURPHY ANDREW J Co-Chief Scientific Officer | Sale 10b5-1 | −202 | $957.53 | $193K | 49,260 |
| 2026-11-17 | MURPHY ANDREW J Co-Chief Scientific Officer | Sale 10b5-1 | −244 | $958.27 | $234K | 49,016 |
| 2026-11-17 | MURPHY ANDREW J Co-Chief Scientific Officer | Sale 10b5-1 | −506 | $959.45 | $485K | 48,510 |
| 2026-11-17 | MURPHY ANDREW J Co-Chief Scientific Officer | Sale 10b5-1 | −257 | $960.65 | $247K | 48,253 |
| 2026-11-17 | MURPHY ANDREW J Co-Chief Scientific Officer | Sale 10b5-1 | −584 | $961.45 | $561K | 47,669 |
| 2026-11-17 | MURPHY ANDREW J Co-Chief Scientific Officer | Sale 10b5-1 | −295 | $962.70 | $284K | 47,374 |
| 2026-11-17 | MURPHY ANDREW J Co-Chief Scientific Officer | Sale 10b5-1 | −255 | $963.60 | $246K | 47,119 |
| 2026-11-17 | MURPHY ANDREW J Co-Chief Scientific Officer | Sale 10b5-1 | −340 | $964.36 | $328K | 46,779 |
| 2026-11-17 | SING GEORGE L Director | Sale | −176 | $956.96 | $168K | 23,971 |
| 2026-11-17 | SING GEORGE L Director | Sale | −359 | $957.49 | $344K | 23,612 |
| 2026-11-17 | SING GEORGE L Director | Sale | −465 | $958.11 | $446K | 23,147 |
| 2026-11-16 | MURPHY ANDREW J Co-Chief Scientific Officer | Exercise or conversion 10b5-1 | +17,000 | $381.92 | $6.5M | 63,779 |
Page 1 of 181 · 3,603 trades